Posted in M&A / Deals Kailera makes history with record-breaking $625m IPO April 17, 2026 Pharmaceutical Technology Kailera’s IPO will allow the biotech to take oral and injectable forms of its lead candidate, ribupatide, through late-stage obesity trials. M&A / DealsRead full story